Condition: COVID · Sponsor: University of California, San Francisco
LIINC is a study of volunteers who were previously infected with SARS-CoV-2 (also known as novel coronavirus or COVID-19) who have recovered from acute infection. The study is designed to provide a specimen bank of samples with carefully characterized clinical data. LIINC specimens will be used to examine multiple questions involving the virologic, immunologic, and host factors involved in COVID-19, with a focus on understanding variability in the long-term immune response between individuals.
This description comes directly from the study's public registry record.
Emily A Fehrman, MPH · (650) 761-2163 · emily.fehrman2@ucsf.edu
Michael J Peluso, MD · 415-476-9363 · michael.peluso@ucsf.edu
Always discuss trial participation with your own doctor first.
| Zuckerberg San Francisco General Hospital (ZSFG) | San Francisco, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04362150